产品详情
Targets
Target | Value |
---|---|
FLT1 | IC50: 8nM |
KDR | IC50: 9nM |
CSF-1R | IC50: 15nM |
LCK | IC50: 22nM |
C-Raf | IC50: 41nM |
Kit | IC50: 80nM |
FLT3 | IC50: 1.303μM |
PDGFRα | IC50: 3.408μM |
Abl | IC50: 4.738μM |
PDGFRβ | IC50: 6.9μM |
EGFR | IC50: >10μM |
AuroraA | IC50: >10μM |
Axl | IC50: >10μM |
CDK2/CyclinA | IC50: >10μM |
IKKβ | IC50: >10μM |
MEK1 | IC50: >10μM |
PDPK1 | IC50: >10μM |
PKBβ | IC50: >10μM |
Tie-2 | IC50: >10μM |
In vitro (25°C) | DMSO | 85 mg/mL (191.68 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.55 mL | 112.76 mL | 225.53 mL |
0.5 mM | 4.51 mL | 22.55 mL | 45.11 mL |
1 mM | 2.26 mL | 11.28 mL | 22.55 mL |
5 mM | 0.45 mL | 2.26 mL | 4.51 mL |
*The above data is based on the productmolecular weight 443.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10679 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 443.4 |
Formula | C22H16F3N3O2S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 728033-96-3 |
Synonyms | OSI930 |
SMILES | C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F |
产品标签
Product Questions
Product Questions
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
SU 5416 (Semaxinib)
SU 5416 (Semaxinib)是血管内皮生长因子受体(VEGFR)的抑制剂,它还抑制其他酪氨酸激酶KIT,MET,FLT3和RET。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…